Andrew Turitz, SVP - Business Development at Teladoc Health, Inc. (TDOC), sold 7,720 shares at $214.63 ($1.6M) on 2021-03-03, disclosed to the SEC on 2021-03-05.
Seasonal sale ($1.6M) by SVP - Business Development — this insider has traded TDOC in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $206.99 | 1,188 | $246K | 15.5% |
| 2 | $206.99 | 1,188 | $246K | 15.5% |
| 3 | $214.63 | 805 | $173K | 10.9% |
| 4 | $214.63 | 805 | $173K | 10.9% |
| 5 | $200.48 | 834 | $167K | 10.5% |
| 6 | $200.48 | 834 |
| $167K |
| 10.5% |
| 7 | $201.25 | 1,033 | $208K | 13.1% |
| 8 | $201.25 | 1,033 | $208K | 13.1% |
| Total | $205.64 avg | 7,720 | $1.6M | 100% |
| Filing → |
| TDOC | SELL | 2024-06-04 | $18K | — | Filing → |
| TDOC | SELL | 2024-03-06 | $164K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $187K | — | Filing → |